Germline mutations in the neurofibromatosis type 2 tumour suppressor gene

David Bourn, Simon A. Carter, Susan Mason, Gareth Evans, Tom Strachan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The recent identification of the NF2 tumour suppressor gene has enabled large scale screening for pathological mutations in the gene. We have sought germline mutations In the NF2 gene by SSCP and heteroduplex analysis of cDNA and genomic DNA samples followed by cloning and sequencing of mutant alleles. In the present report we describe 11 putative pathological mutations, including five nonsense mutations, three short insertions or deletions cauing frameshifts and three missense mutations. Most stop mutations and frameshift mutations were found In Individuals expressing a severe phenotype while one of the three missense mutations was associated with a mild phenotype. Four unrelated NF2 patients of the 93 tested were found to have identical nonsense mutations caused by a C to T transition (C169) in a CpG dinucleotide, which is a potential mutational hotspot in the NF2 tumour suppressor gene.

Original languageEnglish
Pages (from-to)813-816
Number of pages4
JournalHuman Molecular Genetics
Volume3
Issue number5
DOIs
Publication statusPublished - 1 May 1994
Externally publishedYes

Fingerprint

Dive into the research topics of 'Germline mutations in the neurofibromatosis type 2 tumour suppressor gene'. Together they form a unique fingerprint.

Cite this